Literature DB >> 2181024

Biotypes, serogroups and antibiotic susceptibility of Campylobacter jejuni and Campylobacter coli in Chile.

G Figueroa1, M Troncoso, H Galeno, V Soto, M S Toledo.   

Abstract

Phenotypic markers were studied in 105 strains of thermophilic campylobacters isolated from human beings, animals and drinking water in Santiago, Chile. The strains were identified as Campylobacter jejuni (n = 49) and Campylobacter coli (n = 56). Biotypes I and II (Lior schema) accounted for 96% C. jejuni isolates, the other 4% being biotype IV but the two biotypes of C. coli were about equally represented. A total of 28 serogroups (Lior's heat-labile antigens) were identified. Lior 13, 9, 79, 2 and 4 were prevalent among the C. jejuni, while Lior 8, 21 and 29/75 were prevalent among the C. coli isolates. These serogroups accounted for 73% all isolates. The distribution of biotypes and serogroups in patients and asymptomatic persons were similar. Human campylobacters were often resistant to ampicillin (31%) but sensitive to erythromycin and furazolidone. Swine C. coli isolates proved resistant to streptomycin (46%), tetracycline (38%) and erythromycin (15%). Determination of phenotypic and serological characters provides valuable epidemiological markers in the study of campylobacter infections.

Entities:  

Mesh:

Year:  1990        PMID: 2181024     DOI: 10.1016/0163-4453(90)93314-i

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  7 in total

1.  Temporal prevalence of antimicrobial resistance in Campylobacter spp. from beef cattle in Alberta feedlots.

Authors:  G D Inglis; D W Morck; T A McAllister; T Entz; M E Olson; L J Yanke; R R Read
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Effects of subtherapeutic administration of antimicrobial agents to beef cattle on the prevalence of antimicrobial resistance in Campylobacter jejuni and Campylobacter hyointestinalis.

Authors:  G D Inglis; T A McAllister; H W Busz; L J Yanke; D W Morck; M E Olson; R R Read
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Extended phage-typing scheme for Campylobacter jejuni and Campylobacter coli.

Authors:  R Khakhria; H Lior
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

4.  Campylobacter enteritis in Saudi Arabia.

Authors:  R Zaman
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

5.  Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.

Authors:  J L Gomez-Garces; R Cogollos; J L Alos
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

6.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report.

Authors:  E Sjögren; B Kaijser; M Werner
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

7.  Campylobacter antimicrobial resistance in Peru: a ten-year observational study.

Authors:  Simon Pollett; Claudio Rocha; Rito Zerpa; Lilian Patiño; Augusto Valencia; Máximo Camiña; José Guevara; Martha Lopez; Nancy Chuquiray; Eduardo Salazar-Lindo; Carlos Calampa; Martín Casapia; Rina Meza; Maruja Bernal; Drake Tilley; Michael Gregory; Ryan Maves; Eric Hall; Franca Jones; C Sofia Arriola; Marieke Rosenbaum; Juan Perez; Matthew Kasper
Journal:  BMC Infect Dis       Date:  2012-08-16       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.